Autism Biotech
Developing the world’s first biochemical test for the early reliable diagnosis of autism
Autism Biotech develops biochemical test for the early reliable diagnosis of autism. Autism Biotech's product, ASDtect, a diagnostic test for early and reliable detection of autism spectrum disorder. Based on two fully owned and granted patents for peptide biomarkers for autism, ASDtect targets a huge and untapped market. The company is currently conducting trials and aims to make ASDtect available in the near future.
Sep-21-Appears to no longer exist- Website was https://www.autism-biotech.com/
Details last updated 19-Sep-2019